Article Details
Retrieved on: 2021-04-13 08:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
First, Roche announced it was cutting off the dosing of its experimental therapy tominersen, in a closely watched, much-hyped Phase 3 clinical trial.
Article found on: www.statnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here